Emrelis
Telisotuzumab vedotin · AbbVie Inc.
PRESCRIPTION ONLY (USA)Emrelis ingredients
| Active ingredient | Strength |
|---|---|
| Telisotuzumab Vedotin | 100 mg/mL, 20 mg/mL |
What Emrelis is used for
Emrelis is a specialist medicine. Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Emrelis
- Generic name
- Telisotuzumab vedotin
- Made by
- AbbVie Inc.
- Forms
- Injection, Powder, Lyophilized, For Solution
- Given
- Intravenous
- FDA approval
- Biologic licence (BLA) BLA761384
- On the US market since
- 2025
Official information
- Emrelis prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Telisotuzumab vedotin)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Emrelis?
Emrelis (Telisotuzumab vedotin) is a specialist medicine made by AbbVie Inc., approved by the US FDA.
What are the ingredients of Emrelis?
Emrelis contains Telisotuzumab Vedotin (100 mg/mL, 20 mg/mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA